These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 31286571)
1. Using GWAS top hits to inform priors in Bayesian fine-mapping association studies. Walters K; Cox A; Yaacob H Genet Epidemiol; 2019 Sep; 43(6):675-689. PubMed ID: 31286571 [TBL] [Abstract][Full Text] [Related]
2. The utility of the Laplace effect size prior distribution in Bayesian fine-mapping studies. Walters K; Cox A; Yaacob H Genet Epidemiol; 2021 Jun; 45(4):386-401. PubMed ID: 33410201 [TBL] [Abstract][Full Text] [Related]
3. Bayesian variable selection using partially observed categorical prior information in fine-mapping association studies. Alenazi AA; Cox A; Juarez M; Lin WY; Walters K Genet Epidemiol; 2019 Sep; 43(6):690-703. PubMed ID: 31298427 [TBL] [Abstract][Full Text] [Related]
4. Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach. Zhu Q; Shepherd L; Lunetta KL; Yao S; Liu Q; Hu Q; Haddad SA; Sucheston-Campbell L; Bensen JT; Bandera EV; Rosenberg L; Liu S; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB Oncotarget; 2016 Dec; 7(50):83160-83176. PubMed ID: 27825120 [TBL] [Abstract][Full Text] [Related]
5. Re-ranking sequencing variants in the post-GWAS era for accurate causal variant identification. Faye LL; Machiela MJ; Kraft P; Bull SB; Sun L PLoS Genet; 2013; 9(8):e1003609. PubMed ID: 23950724 [TBL] [Abstract][Full Text] [Related]
6. Bayesian multivariant fine mapping using the Laplace prior. Walters K; Yaacob H Genet Epidemiol; 2023 Apr; 47(3):249-260. PubMed ID: 36739616 [TBL] [Abstract][Full Text] [Related]
7. Incorporating Functional Genomic Information in Genetic Association Studies Using an Empirical Bayes Approach. Spencer AV; Cox A; Lin WY; Easton DF; Michailidou K; Walters K Genet Epidemiol; 2016 Apr; 40(3):176-87. PubMed ID: 26833494 [TBL] [Abstract][Full Text] [Related]
8. A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis. Li X; Sham PC; Zhang YD Am J Hum Genet; 2024 Feb; 111(2):213-226. PubMed ID: 38171363 [TBL] [Abstract][Full Text] [Related]
9. Using prior information from the medical literature in GWAS of oral cancer identifies novel susceptibility variant on chromosome 4--the AdAPT method. Johansson M; Roberts A; Chen D; Li Y; Delahaye-Sourdeix M; Aswani N; Greenwood MA; Benhamou S; Lagiou P; Holcátová I; Richiardi L; Kjaerheim K; Agudo A; Castellsagué X; Macfarlane TV; Barzan L; Canova C; Thakker NS; Conway DI; Znaor A; Healy CM; Ahrens W; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Fabiánová E; Mates IN; Bencko V; Foretova L; Janout V; Curado MP; Koifman S; Menezes A; Wünsch-Filho V; Eluf-Neto J; Boffetta P; Franceschi S; Herrero R; Fernandez Garrote L; Talamini R; Boccia S; Galan P; Vatten L; Thomson P; Zelenika D; Lathrop M; Byrnes G; Cunningham H; Brennan P; Wakefield J; McKay JD PLoS One; 2012; 7(5):e36888. PubMed ID: 22662130 [TBL] [Abstract][Full Text] [Related]
10. Improving the coverage of credible sets in Bayesian genetic fine-mapping. Hutchinson A; Watson H; Wallace C PLoS Comput Biol; 2020 Apr; 16(4):e1007829. PubMed ID: 32282791 [TBL] [Abstract][Full Text] [Related]
11. Novel bayes factors that capture expert uncertainty in prior density specification in genetic association studies. Spencer AV; Cox A; Lin WY; Easton DF; Michailidou K; Walters K Genet Epidemiol; 2015 May; 39(4):239-48. PubMed ID: 25727067 [TBL] [Abstract][Full Text] [Related]
12. From candidate gene studies to GWAS and post-GWAS analyses in breast cancer. Fachal L; Dunning AM Curr Opin Genet Dev; 2015 Feb; 30():32-41. PubMed ID: 25727315 [TBL] [Abstract][Full Text] [Related]
13. A Bayesian method to incorporate hundreds of functional characteristics with association evidence to improve variant prioritization. Gagliano SA; Barnes MR; Weale ME; Knight J PLoS One; 2014; 9(5):e98122. PubMed ID: 24844982 [TBL] [Abstract][Full Text] [Related]
14. SparsePro: An efficient fine-mapping method integrating summary statistics and functional annotations. Zhang W; Najafabadi H; Li Y PLoS Genet; 2023 Dec; 19(12):e1011104. PubMed ID: 38153934 [TBL] [Abstract][Full Text] [Related]
15. Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics. Chen W; Larrabee BR; Ovsyannikova IG; Kennedy RB; Haralambieva IH; Poland GA; Schaid DJ Genetics; 2015 Jul; 200(3):719-36. PubMed ID: 25948564 [TBL] [Abstract][Full Text] [Related]
16. GWASinlps: non-local prior based iterative SNP selection tool for genome-wide association studies. Sanyal N; Lo MT; Kauppi K; Djurovic S; Andreassen OA; Johnson VE; Chen CH Bioinformatics; 2019 Jan; 35(1):1-11. PubMed ID: 29931045 [TBL] [Abstract][Full Text] [Related]
17. An algorithm for direct causal learning of influences on patient outcomes. Rathnam C; Lee S; Jiang X Artif Intell Med; 2017 Jan; 75():1-15. PubMed ID: 28363452 [TBL] [Abstract][Full Text] [Related]
18. Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases. Dudbridge F; Fletcher O; Walker K; Johnson N; Orr N; Dos Santos Silva I; Peto J Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):262-72. PubMed ID: 22028405 [TBL] [Abstract][Full Text] [Related]
19. BGWAS: Bayesian variable selection in linear mixed models with nonlocal priors for genome-wide association studies. Williams J; Xu S; Ferreira MAR BMC Bioinformatics; 2023 May; 24(1):194. PubMed ID: 37170185 [TBL] [Abstract][Full Text] [Related]
20. A latent model for prioritization of SNPs for functional studies. Fridley BL; Iversen E; Tsai YY; Jenkins GD; Goode EL; Sellers TA PLoS One; 2011; 6(6):e20764. PubMed ID: 21687685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]